KEGG   Gracilinanus agilis (agile gracile opossum): 123232391
Entry
123232391         CDS       T07702                                 
Name
(RefSeq) caspase-3-like
  KO
K02187  caspase 3 [EC:3.4.22.56]
Organism
gas  Gracilinanus agilis (agile gracile opossum)
Pathway
gas01524  Platinum drug resistance
gas04010  MAPK signaling pathway
gas04115  p53 signaling pathway
gas04148  Efferocytosis
gas04210  Apoptosis
gas04215  Apoptosis - multiple species
gas04623  Cytosolic DNA-sensing pathway
gas04650  Natural killer cell mediated cytotoxicity
gas04657  IL-17 signaling pathway
gas04668  TNF signaling pathway
gas04726  Serotonergic synapse
gas04932  Non-alcoholic fatty liver disease
gas04933  AGE-RAGE signaling pathway in diabetic complications
gas04936  Alcoholic liver disease
gas05010  Alzheimer disease
gas05012  Parkinson disease
gas05014  Amyotrophic lateral sclerosis
gas05016  Huntington disease
gas05020  Prion disease
gas05022  Pathways of neurodegeneration - multiple diseases
gas05132  Salmonella infection
gas05133  Pertussis
gas05134  Legionellosis
gas05145  Toxoplasmosis
gas05146  Amoebiasis
gas05152  Tuberculosis
gas05160  Hepatitis C
gas05161  Hepatitis B
gas05162  Measles
gas05163  Human cytomegalovirus infection
gas05164  Influenza A
gas05165  Human papillomavirus infection
gas05167  Kaposi sarcoma-associated herpesvirus infection
gas05168  Herpes simplex virus 1 infection
gas05169  Epstein-Barr virus infection
gas05170  Human immunodeficiency virus 1 infection
gas05200  Pathways in cancer
gas05203  Viral carcinogenesis
gas05205  Proteoglycans in cancer
gas05206  MicroRNAs in cancer
gas05210  Colorectal cancer
gas05222  Small cell lung cancer
gas05416  Viral myocarditis
gas05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:gas00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    123232391
   04668 TNF signaling pathway
    123232391
 09140 Cellular Processes
  09141 Transport and catabolism
   04148 Efferocytosis
    123232391
  09143 Cell growth and death
   04210 Apoptosis
    123232391
   04215 Apoptosis - multiple species
    123232391
   04115 p53 signaling pathway
    123232391
 09150 Organismal Systems
  09151 Immune system
   04623 Cytosolic DNA-sensing pathway
    123232391
   04650 Natural killer cell mediated cytotoxicity
    123232391
   04657 IL-17 signaling pathway
    123232391
  09156 Nervous system
   04726 Serotonergic synapse
    123232391
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    123232391
   05206 MicroRNAs in cancer
    123232391
   05205 Proteoglycans in cancer
    123232391
   05203 Viral carcinogenesis
    123232391
  09162 Cancer: specific types
   05210 Colorectal cancer
    123232391
   05222 Small cell lung cancer
    123232391
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    123232391
   05161 Hepatitis B
    123232391
   05160 Hepatitis C
    123232391
   05164 Influenza A
    123232391
   05162 Measles
    123232391
   05168 Herpes simplex virus 1 infection
    123232391
   05163 Human cytomegalovirus infection
    123232391
   05167 Kaposi sarcoma-associated herpesvirus infection
    123232391
   05169 Epstein-Barr virus infection
    123232391
   05165 Human papillomavirus infection
    123232391
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    123232391
   05133 Pertussis
    123232391
   05134 Legionellosis
    123232391
   05152 Tuberculosis
    123232391
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    123232391
   05145 Toxoplasmosis
    123232391
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    123232391
   05012 Parkinson disease
    123232391
   05014 Amyotrophic lateral sclerosis
    123232391
   05016 Huntington disease
    123232391
   05020 Prion disease
    123232391
   05022 Pathways of neurodegeneration - multiple diseases
    123232391
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    123232391
   05416 Viral myocarditis
    123232391
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    123232391
   04932 Non-alcoholic fatty liver disease
    123232391
   04933 AGE-RAGE signaling pathway in diabetic complications
    123232391
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    123232391
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01002 Peptidases and inhibitors [BR:gas01002]
    123232391
Enzymes [BR:gas01000]
 3. Hydrolases
  3.4  Acting on peptide bonds (peptidases)
   3.4.22  Cysteine endopeptidases
    3.4.22.56  caspase-3
     123232391
Peptidases and inhibitors [BR:gas01002]
 Cysteine peptidases
  Family C14: caspase family
   123232391
SSDB
Motif
Pfam: Peptidase_C14 Tachystatin_B
Other DBs
NCBI-GeneID: 123232391
NCBI-ProteinID: XP_044514754
LinkDB
Position
1:760284036..760284866
AA seq 276 aa
MEDTGTTVDSKSTKISGIKSLHDSNSVEPGLSLDSYKMDYPEMGLCVIINNKDFDKDTEL
LSRNGTEKDAANLKDIFKSLKYEVRYKNNLTCKEIINYLKSVSREDHSQRSSFVCVILSH
GEEGVIFGTDGSVELKSLTCFFRGDKCRSLTGKPKLFIIQACQGTELDSGVQTDSGTDED
VACQKIPVEADFLYAYSTVPGYYSWRNSKDGLWFIQALCAVLKQYAHKLEIMQLLTQVNR
KVATEIESYSLDISFHGKKQVPCIMSMLTKELYFFH
NT seq 831 nt   +upstreamnt  +downstreamnt
atggaagacactggaactacagtagactcaaaatccaccaaaatttcaggaataaagagc
ctccatgatagcaattcagtggaacctggactatcattagacagttataaaatggattat
ccagaaatggggctatgtgtaataatcaataataaagattttgacaaagacactgaactt
ttatctcggaatggtacagaaaaagatgcagcaaacctcaaggatatattcaaaagcttg
aaatatgaagtcaggtataaaaacaatctgacctgtaaagaaataattaactacttgaag
agtgtttctagagaagatcacagccaaaggagcagttttgtttgtgtgattctaagtcat
ggtgaagaaggagtcatctttggcacagatggatctgttgaactgaaaagtttaacatgc
ttctttagaggagataagtgtagaagcttaacaggaaaacccaagctttttattattcag
gcatgccaagggacagagctggatagtggtgttcagacagacagtggtacagatgaagat
gtagcatgccagaaaatacctgttgaagctgacttcttatatgcatattcaacagtccct
ggctattattcctggagaaattcaaaggatggtttgtggtttattcaggcactttgtgca
gtgctcaaacagtatgctcacaagcttgagattatgcaactccttacccaagtcaatcgg
aaggtggccacagagattgaatcttattccttagacatttccttccatggaaagaagcag
gtgccatgtattatgtccatgcttaccaaggaactgtattttttccattga

DBGET integrated database retrieval system